Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis
- 30 July 2001
- Vol. 19 (31) , 4465-4472
- https://doi.org/10.1016/s0264-410x(01)00189-x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Recent developments in bacterial conjugate vaccinesJournal of Medical Microbiology, 1998
- R-form lipopolysaccharides (LPS) of Gram-negative bacteria as possible vaccine antigensFEMS Immunology & Medical Microbiology, 1997
- Role of two outer membrane antigens in the induction of protective immunity againstFrancisella tularensisstrains of different virulenceFEMS Immunology & Medical Microbiology, 1996
- Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensisVaccine, 1995
- Passive Protection of Mice Against Lethal Francisella Tularensis (Live Tularemia Vaccine Strain) Infection by the Sera of Human Recipients of the Live Tularemia VaccineThe Lancet Healthy Longevity, 1994
- The tularaemia vaccineJournal of Chemical Technology & Biotechnology, 1994
- Monoclonal antibodies to promote marrow engraftment and tissue graft toleranceNature, 1986
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- Immunization against Tularemia: Analysis of the Effectiveness of Live Francisella tularensis Vaccine in Prevention of Laboratory-Acquired TularemiaThe Journal of Infectious Diseases, 1977
- Antitularemic SerumPublic Health Reports (1896-1970), 1942